161 释放Tb-PSMA:前列腺癌治疗学的有前途的新参与者

相关实验视频

Updated: Jul 22, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Akram Al-Ibraheem^1,2, Andrew M Scott^3,4,5,6

¹Department of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), P.O. Box 1269, Al-Jubeiha, Amman, 11941 Jordan.

Nuclear medicine and molecular imaging

|July 24, 2023

概括

-161 (161Tb) -PSMA放射性对象疗法在前列腺癌治疗方面显示出前景. 初步的人体试验表明,转移性割抵抗性前列腺癌 (mCRPC) 的耐受性良好,安全的治疗选择.

科学领域:

核医学是一种核医学.
在瘤学瘤学.
放射性药物疗法是一种放射性药物疗法.

背景情况:

卢-177 (177Lu) -PSMA放射性透射剂已成为前列腺癌治疗的标准.
-161 (161Tb) 正在作为一种新型放射性核化物用于治疗癌症放射性瘤,包括转移性割抵抗性前列腺癌 (mCRPC).

研究的目的:

审查前列腺癌中放射性射的当前情况.
讨论161Tb-PSMA作为一种新的治疗选择的潜力.
为了突出前列腺癌的挑战和未来方向.

主要方法:

关于177Lu-PSMA和新兴的161Tb-PSMA疗法的当前文献综述.
对161Tb-PSMA放射性干疗法的首次人体临床试验结果的分析.
讨论正在进行的161Tb-PSMA临床试验.

主要成果:

第一次在人体中使用161Tb-PSMA放射性干治疗的SPECT/CT成像结果报告说耐受良好.
在最初的人类研究中没有观察到与治疗相关的不良事件.
目前正在进行两项针对161Tb-PSMA的临床试验.

结论:

161Tb-PSMA代表了前列腺癌辐射疗法的一个有希望的进步.
这种新疗法可能会解决现有的挑战,并建立在177Lu-PSMA的成功之上.
进一步的临床试验至关重要,以确定161Tb-PSMA在前列腺癌患者的疗效和安全性.

关键词:

161Tb-PSMA 是一个约旦约旦约旦约旦侯赛因国王癌症中心 (KHCC)核医学是一种核医学.前列腺癌是什么意思前列腺癌是什么意思无线电听器是一种无线电听器.

更多相关视频

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...